DE60127965D1 - Nachweis viraler agentien in brustmilchkanälen und antivirale therapie - Google Patents

Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Info

Publication number
DE60127965D1
DE60127965D1 DE60127965T DE60127965T DE60127965D1 DE 60127965 D1 DE60127965 D1 DE 60127965D1 DE 60127965 T DE60127965 T DE 60127965T DE 60127965 T DE60127965 T DE 60127965T DE 60127965 D1 DE60127965 D1 DE 60127965D1
Authority
DE
Germany
Prior art keywords
antiviral therapy
identification
breast milk
viral agents
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127965T
Other languages
English (en)
Other versions
DE60127965T2 (de
Inventor
David Hung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytyc Corp
Original Assignee
Cytyc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytyc Corp filed Critical Cytyc Corp
Publication of DE60127965D1 publication Critical patent/DE60127965D1/de
Application granted granted Critical
Publication of DE60127965T2 publication Critical patent/DE60127965T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60127965T 2000-08-08 2001-08-08 Nachweis viraler agentien in brustmilchkanälen und antivirale therapie Expired - Lifetime DE60127965T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22385700P 2000-08-08 2000-08-08
US223857P 2000-08-08
PCT/US2001/024770 WO2002012900A1 (en) 2000-08-08 2001-08-08 Identification of viral agents in breast ducts and antiviral therapy therefore

Publications (2)

Publication Number Publication Date
DE60127965D1 true DE60127965D1 (de) 2007-05-31
DE60127965T2 DE60127965T2 (de) 2007-12-20

Family

ID=22838235

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127965T Expired - Lifetime DE60127965T2 (de) 2000-08-08 2001-08-08 Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Country Status (9)

Country Link
US (2) US7132232B2 (de)
EP (1) EP1307746B1 (de)
JP (1) JP2004505621A (de)
AT (1) ATE360209T1 (de)
AU (2) AU2001281161B2 (de)
DE (1) DE60127965T2 (de)
ES (1) ES2284672T3 (de)
HK (1) HK1055462A1 (de)
WO (1) WO2002012900A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110609A1 (en) * 1998-12-28 2002-08-15 David Hung Increasing retrievable fluid from a breast duct
US6471660B1 (en) 1999-01-21 2002-10-29 Chandice Covington Method and apparatus for measuring factors in mammary fluids
AU769853B2 (en) * 1999-06-11 2004-02-05 Atossa Genetics, Inc. Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
EP1307746B1 (de) * 2000-08-08 2007-04-18 Cytyc Corporation Nachweis viraler agentien in brustmilchkanälen und antivirale therapie
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
JP2008514900A (ja) 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169774A (en) 1984-02-08 1992-12-08 Cetus Oncology Corporation Monoclonal anti-human breast cancer antibodies
JP3040121B2 (ja) 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
IT1251542B (it) 1991-03-06 1995-05-17 D D S R L Dispositivo per il lavaggio a scopo terapeutico o di igiene di condotti interni del corpo umano o animale, che consente il drenaggio del liquido di lavaggio
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
US6221622B1 (en) 1998-04-28 2001-04-24 The Regents Of The University Of California Method and kit for obtaining fluids and cellular material from breast ducts
US6413228B1 (en) 1998-12-28 2002-07-02 Pro Duct Health, Inc. Devices, methods and systems for collecting material from a breast duct
US6638727B1 (en) 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
JP2003535617A (ja) * 1999-03-01 2003-12-02 プロ ダクト ヘルス インコーポレーティッド 多数の乳管に物質を同時に送達するための装置、方法、およびキット
EP1307746B1 (de) * 2000-08-08 2007-04-18 Cytyc Corporation Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Also Published As

Publication number Publication date
AU8116101A (en) 2002-02-18
EP1307746B1 (de) 2007-04-18
US20020045162A1 (en) 2002-04-18
US20070009946A1 (en) 2007-01-11
ATE360209T1 (de) 2007-05-15
ES2284672T3 (es) 2007-11-16
US7405045B2 (en) 2008-07-29
EP1307746A1 (de) 2003-05-07
HK1055462A1 (en) 2004-01-09
DE60127965T2 (de) 2007-12-20
JP2004505621A (ja) 2004-02-26
WO2002012900A1 (en) 2002-02-14
AU2001281161B2 (en) 2007-08-23
US7132232B2 (en) 2006-11-07

Similar Documents

Publication Publication Date Title
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
DK0392429T3 (da) Psoralen-reagens
ATE500808T1 (de) Onkolytische virustherapie
ATE245641T1 (de) Antivirale pyrimidinderivate
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
DE60117615D1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
NO20091761L (no) Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav
DK486588A (da) Konjungater af cytokininer med immunglobuliner
CY1105408T1 (el) Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου
BR9712366A (pt) Gene de gd2 do vírus do herpes simples hsv2 isolado, plasmídeo compreendendo o mesmo, e, processos de induzir, em indivíduo, uma resposta imune contra hsv2 gd2, de tratar um indíviduo que está infectado com hsv, e, de prevenir que um indivíduo fique infectado com hsv
DE60127965D1 (de) Nachweis viraler agentien in brustmilchkanälen und antivirale therapie
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DE68912155D1 (de) Antivirales Kombinationspräparat.
DE60129358D1 (de) Genetische immunisierung gegen zervixkarzinom
BR0016163A (pt) Tratamento de infecções virais que usa levovirin(r)
NO20041855L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon ved behandling av feilpasienter
EP1785727A3 (de) Identifizierung viraler Erreger in Brustgängen und Antivirustherapie dafür
GB9827104D0 (en) New cancer treatments
PT948967E (pt) Tratamento de doencas virais em suicos
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
HUP9901299A2 (hu) Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8380 Miscellaneous part iii

Free format text: PFANDRECHT